Trovagene, Genomac Expand Cancer Collaboration | GenomeWeb

NEW YORK (GenomeWeb) – Trovagene today announced the expansion of a clinical collaboration with Genomac Research Institute using the company's technology for the early detection of emerging oncogene mutations associated with resistance to targeted lung and colorectal cancer therapies. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.